Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015

about

Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015

Item

http://www.wikidata.org/entity/Q57826130

description

im Februar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2018

@uk

name

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@en

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@nl

type

Item

label

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@en

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@nl

prefLabel

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@en

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@nl

P1476

Trends in Neonatal Prophylaxis ...... n US Infants from 1990 to 2015

@en

P2093

Ellen G Chadwick

http://www.w3.org/2001/XMLSchema#string

Kathryn Rough

http://www.w3.org/2001/XMLSchema#string

Paige L Williams

http://www.w3.org/2001/XMLSchema#string

Richard Rutstein

http://www.w3.org/2001/XMLSchema#string

Rohan Hazra

http://www.w3.org/2001/XMLSchema#string

Russell B Van Dyke

http://www.w3.org/2001/XMLSchema#string

Yanling Huo

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

A modified poisson regression approach to prospective studies with binary data

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.

In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.

A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers

Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe.

P304

48-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/APC.2017.0295

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30346801

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

5808381

http://www.w3.org/2001/XMLSchema#string